Møre og Romsdal Hospital Trust
12
3
6
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
2 terminated/withdrawn out of 12 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Unrefined Salmon Oil as Dietary Supplement in Patient With Chronic Obstructive Pulmonary Disease
Role: collaborator
Unrefined Salmon Oil as Dietary Supplement in Adult Asthmatics
Role: collaborator
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Bone Mass Among Osteopenic Women
Role: collaborator
Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors
Role: collaborator
Precision Cancer Therapy in Rare Cancers
Role: collaborator
The NORDSTEN Study - Degenerative Spondylolisthesis
Role: collaborator
The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19
Role: collaborator
Presence of PTSD and Emotion Dysregulation Among Inpatients With Substance Use Disorder
Role: collaborator
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
Role: collaborator
The NORDSTEN Studies/The Observational Cohort Study
Role: collaborator
The NORDSTEN Studies/ The Spinal Stenosis Study
Role: collaborator
Mecillinam for Treatment of Genital Chlamydia Infection
Role: collaborator
All 12 trials loaded